IL4 and breast carcinoma: Gingras et al. [34] reported that IL4 induces the phosphorylation of IRS1 and IRS2, leading to downstream PI3K activation, which is crucial for IL4-mediated 3β-HSD activity in ZR-75-1 human breast cancer cell lines.